British Journal of Cancer - Table of Contents alert Volume 106 Issue 8

TABLE OF CONTENTS Volume 106, Issue 8 (1361-1466) Published online 10 April 2012 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Letters to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press? Internet chemotherapy information: impact on patients and health professionals E Davies and K-W Yeoh Read this Article now!   Clinical Studies Top Major ethnic group differences in breast cancer screening uptake in Scotland are not extinguished by adjustment for indices of geographical residence, area deprivation, long-term illness and education N Bansal, R S Bhopal, M F C Steiner and D H Brewster on behalf of the Scottish Health and Ethnicity Linkage Study Br J Cancer 2012 106: 1361-1366; advance online publication, March 13, 2012; 10.1038/bjc.2012.83 Abstract | Full Text Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas A Gallardo, E Lerma, D Escuin, A Tibau, J Muñoz, B Ojeda, A Barnadas, E Adrover, L Sánchez-Tejada, D Giner, F Ortiz-Martínez and G Peiró Br J Cancer 2012 106: 1367-1373; advance online publication, March 27, 2012; 10.1038/bjc.2012.85 Abstract | Full Text Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer C R Garrett, H M Hassabo, N A Bhadkamkar, S Wen, V Baladandayuthapani, B K Kee, C Eng and M M Hassan Br J Cancer 2012 106: 1374-1378; advance online publication, March 15, 2012; 10.1038/bjc.2012.71 Abstract | Full Text First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours T A Yap, H Cortes-Funes, H Shaw, R Rodriguez, D Olmos, R Lal, P C Fong, D S Tan, D Harris, J Capdevila, C Coronado, V Alfaro, A Soto-Matos, C Fernández-Teruel, M Siguero, J M Tabernero, L Paz-Ares, J S de Bono and J A López-Martin Br J Cancer 2012 106: 1379-1385; 10.1038/bjc.2012.99 Abstract | Full Text Translational Therapeutics Top The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition E J Haagensen, S Kyle, G S Beale, R J Maxwell and D R Newell Br J Cancer 2012 106: 1386-1394; advance online publication, March 13, 2012; 10.1038/bjc.2012.70 Abstract | Full Text Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cells U Stein, C Fleuter, F Siegel, J Smith, A Kopacek, D A Scudiero, K M Hite, P M Schlag, R H Shoemaker and W Walther Br J Cancer 2012 106: 1395-1405; advance online publication, March 29, 2012; 10.1038/bjc.2012.81 Abstract | Full Text Molecular Diagnostics Top Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells C Oliveras-Ferraros, S Cufí, B Queralt, A Vazquez-Martin, B Martin-Castillo, R de Llorens, J Bosch-Barrera, J Brunet and J A Menendez Br J Cancer 2012 106: 1406-1414; 10.1038/bjc.2012.103 Abstract | Full Text High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer R Hamano, H Miyata, M Yamasaki, K Sugimura, K Tanaka, Y Kurokawa, K Nakajima, S Takiguchi, Y Fujiwara, M Mori and Y Doki Br J Cancer 2012 106: 1415-1423; advance online publication, March 20, 2012; 10.1038/bjc.2012.90 Abstract | Full Text Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening S Tao, U Haug, K Kuhn and H Brenner Br J Cancer 2012 106: 1424-1430; advance online publication, March 27, 2012; 10.1038/bjc.2012.104 Abstract | Full Text Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test S Wilson, S Damery, D D Stocken, G Dowswell, R Holder, S T Ward, V Redman, M J Wakelam, J James, F D R Hobbs and T Ismail Br J Cancer 2012 106: 1431-1438; advance online publication, March 20, 2012; 10.1038/bjc.2012.93 Abstract | Full Text A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) D J Pinato, B V North and R Sharma Br J Cancer 2012 106: 1439-1445; advance online publication, March 20, 2012; 10.1038/bjc.2012.92 Abstract | Full Text NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity H Wang, S Lee, C Lo Nigro, L Lattanzio, M Merlano, M Monteverde, R Matin, K Purdie, N Mladkova, D Bergamaschi, C Harwood, N Syed, P Szlosarek, E Briasoulis, A McHugh, A Thompson, A Evans, I Leigh, C Fleming, G J Inman, E Hatzimichael, C Proby and T Crook Br J Cancer 2012 106: 1446-1452; advance online publication, March 27, 2012; 10.1038/bjc.2012.95 Abstract | Full Text Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer J Ohotski, J S Long, C Orange, B Elsberger, E Mallon, J Doughty, S Pyne, N J Pyne and J Edwards Br J Cancer 2012 106: 1453-1459; advance online publication, March 29, 2012; 10.1038/bjc.2012.98 Abstract | Full Text Genetics and Genomics Top Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families D J Osher, K De Leeneer, G Michils, N Hamel, E Tomiak, B Poppe, K Leunen, E Legius, A Shuen, E Smith, J Arseneau, P Tonin, G Matthijs, K Claes, M D Tischkowitz and W D Foulkes Br J Cancer 2012 106: 1460-1463; advance online publication, March 13, 2012; 10.1038/bjc.2012.87 Abstract | Full Text Letters to the Editor Top Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate P D Dickinson, D N Y Peel and S Sundar Br J Cancer 2012 106: 1464-1465; advance online publication, March 13, 2012; 10.1038/bjc.2012.78 Full Text Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate O A Khan, A D Blann, M J Payne, M R Middleton, A S Protheroe, D C Talbot, M Taylor, C Han, M Patil and A L Harris Br J Cancer 2012 106: 1466; advance online publication, March 13, 2012; 10.1038/bjc.2012.79 Full Text Advertisement British Journal of Cancer presents:  Web Focus on MicroRNA MicroRNAs have emerged as major new mechanisms of regulation of gene function, potential therapeutic targets, with roles in diagnosis, prognosis and biomarkers. This collection puts MicroRNA in context of other molecular classifications and then investigative articles and reviews cover the main tumour types where microRNAs are emerging as having important roles in biological processes including lung cancer, AML, melanoma, colorectal cancer, nasopharyngeal carcinoma, bladder cancer, rhabdomyosarcoma and heptacellular carcinoma.  Read the articles for FREE   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.